J&J JNJ stock has risen more than 6% in the past month. The reason behind the increase was a strong-than-expected ...

A select group of business and diplomatic leaders were given a sneak-peak on Feb. 18 of the candidates for the Expat CEO and ...

The hearing, which commenced on Tuesday, 18 February, 2025, is being overseen by US Bankruptcy Judge Christopher Lopez in ...

A select group of business and diplomatic leaders were given a sneak-peak on Feb. 18 of the candidates for the Expat CEO and CEO Community awards, to be presented by the BBJ and event partner Hipa on ...

Omnicom’s PHD maintained its top spot in the final 2024 global media league after earning around $3.6bn (£2.8bn) in net ...

It has been about a month since the last earnings report for Johnson & Johnson (JNJ). Shares have added about 8.9% in that time frame, outperforming the S&P 500. Will the recent positive trend ...

A UK biotech start-up has gained a sought after ‘promising innovative medicine’ (PIM) designation for its ultra-rare disease gene therapy. Orchard Therapeutics was only set up two years ago ...

Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow ...

Tremfya could become the first IL-23 inhibitor with fully subcutaneous induction and maintenance options in the treatment of ...

Omnicom Media Group led the rankings with over $1 billion in net new-business billings, the only agency last year to hit that milestone. Stay informed with Campaign US, your go-to source for exclusive ...

Joaquin Lasso, SVP of Sports Medicine, International Markets for Smith+Nephew. “This technology allows surgeons to personalise their treatment for each patient and returns them to living their ...